Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...
The collaboration combines Tenovi's Cellular Gateway and Modivcare's chronic condition management service offerings to create a cost-effective ecosystem that helps healthcare providers deliver a ...
John Ruttle has a condition that kills 7600 Australians a year, but half of people with it don’t know it. One small tweak ...
Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...
Honeywell Solstice® Air can cut metered dose inhaler greenhouse gas emissions of up to 99.9% versus current propellants1 CHARLOTTE, N.C., October, 2024 – Honeywell (NASDAQ: HON) today announced a long ...
The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...
The global metered dose inhalers (MDI) market is poised for significant growth, with an estimated market size of USD 26,322.9 million in 2023, up from USD 25,208.9 million in 2022. According to a ...
Chronic obstructive pulmonary disease (COPD) presents a significant challenge for both patients and health care providers and discussions of effective management strategies took center stage at CHEST ...
The increasing demand for asthma treatment is largely driven by the rising number of asthma cases. Factors such as increased smoking and air pollution are impairing lung function and contributing to ...
The global asthma treatment market size was valued at USD 27.51 billion in 2023 and is expected to reach around USD 35.93 billion by 2034. It is growing at a CAGR of 2.42% from 2024 and 2034. The ...
Inhalers used to treat symptoms of respiratory disease can be potent sources of greenhouse gases. Drugmakers are planning to ...
In addition to dashboard links, we have also shared links to other existing, relevant data sources that could support implementation. Structured medication reviews (SMRs) can be used to review ...